1. Medtech Insight
  2. >>Geography

Vibrant IVDs Innovation Climate At Risk From Poor UK Regulatory System Readiness

 
• By Ashley Yeo

The spotlight is on IVDs in the post-COVID phase. Innovators in university spin-outs and the established industry have responded with new technologies, creating a vibrant scene. Regulators and reimbursors must not disrupt the momentum, say BIVDA’s regulatory affairs manager Ashleigh Batchen and chief executive Doris-Ann Williams.

Shutterstock

After the delay, the lull.

The UK government took longer than anticipated in delivering its official response to the Medicines and Healthcare products Regulatory Agency’s (MHRA) consultation on the country’s future medical device regulatory system. The reasons advanced were local government election purdah and ongoing work on the post-Brexit Northern Ireland protocol

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

More from Europe